Datavant, AWS Ink SCA for Cloud-First Healthcare Data Solutions
Datavant, the leading health data platform company, today announced it has signed a multi-year Strategic Collaboration Agreement (SCA) with Amazon Web Services (AWS), to power...
Tag : cancer biomarkers
CND Life Sciences Expands Leadership with Four Key Exec Appointments
Enhances mission to advance the care of patients facing the potential diagnosis of a neurodegenerative disease CND Life Sciences (CND), a medical technology company pioneering the...
Proscia & Nucleai partner to broaden access to AI predictive biomarkers
Expanding Proscia’s precision medicine AI pipeline will help to optimize clinical trials and improve treatment decisions Proscia®, a global leader in AI-enabled pathology solutions for...
Nucleai Appoints Vikas Ahuja as VP of Strategic Partnerships
Vikas Ahuja brings over 20 years of strategic business experience in the life sciences industry from Quest Diagnostics, Ambry Genetics and Mallinckrodt Pharmaceuticals Nucleai, a...
Fountain Life Introduced Fountain Life CORE
Fountain Life CORE provides a recurring, comprehensive, longevity-focused blood panel paired with expert analysis and ongoing guidance from a Fountain Life longevity physician and health...
Beckman Coulter and MeMed to Advance Host Immune Response Diagnostics
Beckman Coulter Now an Authorized Distributor of MeMed Key Immunoassay System and MeMed BV Assay Progress Continues on Original Collaboration to Develop a MeMed BV-Based Assay...
Imaging Endpoints Unveils New Initiative with Revolution Endpoints™
Imaging Endpoints (IE), a global leader in Imaging CRO technologies and services, has announced the formation of a new subsidiary, Revolution Endpoints, focused on leveraging...
Nucleai and GoPath Diagnostics announce strategic collaboration
Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic outcomes, today announced a strategic...
Ambry Genetics announces a collaboration with Tempus
Ambry Genetics (Ambry), a leader in clinical diagnostic testing, and Tempus, a leader in artificial intelligence and precision medicine, announced today that they have entered into a...
Paige expands AppLab Marketplace with 6 new Digital Pathology Providers
Paige deepens its AppLab’s offerings by partnering with industry-leading third-party AI providers Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications...